Board of Directors

Meet the Cogstate Board of Directors who bring a wealth of knowledge and experience to our business.

The Cogstate Board of Directors bring a broad set of collective skills and expertise in corporate sectors, including energy, infrastructure, financial services, biopharmaceutical research and medical device and diagnostics.

Brad O’Connor

Brad O’Connor

Chief Executive Officer

Brad O’Connor has been Managing Director and Chief Executive Officer of Cogstate Limited since December 2005. He has responsibility for Cogstate’s overall strategic direction and day-to-day operations as well as development of expansion opportunities outside of the core clinical trials business.

Martyn Myer AO

Martyn Myer AO

Chairman

Mr Myer sits on the Fishermans Bend board, a Victorian Government board charged with developing the Fishermans Bend precinct, and the boards of the Australian Chamber Orchestra and Watertrust Australia Limited.

David Dolby

David Dolby

Non-Executive Director

David Dolby is an independent investor representing the Dolby Family Trust on a variety of technology investments in pharmaceutical research and drug development, health monitoring devices, computer vision, aerospace, consumer media and entertainment technologies, as well as philanthropic ventures for the Ray and Dagmar Dolby Family Fund.

Richard van den Broek

Richard van den Broek

Independent Non-Executive Director

Mr van den Broek is founder and managing partner of HSMR Advisors LLC, a U.S. based fund manager with an investment emphasis on small and mid-cap biotech public companies. From 2000 through 2003 he was a Partner at Cooper Hill Partners, LLC, an investment fund focused on the healthcare sector.

Richard Mohs

Richard Mohs

Independent Non-Executive Director

Dr. Mohs retired from Eli Lilly in 2015, where he held several leadership positions. Before joining Eli Lilly in 2002, Dr. Mohs spent 23 years with the Mount Sinai School of Medicine in NY where he was Professor in the Department of Psychiatry and Associate Chief of Staff for Research at the Bronx Veterans Affairs Medical Center.

Ingrid Player

Ingrid Player

Independent Non-Executive Director

Ms Player brings deep healthcare sector experience and strong commercial expertise to the Board of Cogstate.  She has held senior executive roles with Healthscope Ltd, a leading private healthcare provider in Australia, including the former positions of Group Executive – Legal, Governance and Sustainability, and General Counsel and Company Secretary from 2005 until 2019.

Kim Wenn

Kim Wenn

Independent Non-Executive Director

Ms Wenn brings extensive technology experience and strong commercial expertise to the Board of Cogstate, with over 30 years experience in innovation roles. Until July 2018, Kim held the role of Chief Information Officer at Tabcorp Holdings, an ASX50 listed company where Kim led a team of 1,200 technology experts to drive strategic direction through digital transformation.

David Franks

David Franks

Company Secretary

Mr Franks is a Director and Principal of the Automic Group. He is a Chartered Accountant, Fellow of the Financial Services Institute of Australia, Fellow of the Governance Institute of Australia, Justice of the Peace, Registered Tax Agent and holds a Bachelor of Economics (Finance and Accounting) from Macquarie University.

Receive Investor Updates

Please fill out the form to subscribe